SCHEMBL16655278

SCHEMBL16655278

CC1(NC(=O)O)CCCC1NC(=O)c1ccccc1-n1nccn1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 20/20 0.65
HCRTR2 O43614 8/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16655158 0.86 HCRTR1 (0.62) HCRTR1HCRTR2
SCHEMBL17017449 0.84 HCRTR1 (0.80) HCRTR1HCRTR2
SCHEMBL17017434 0.84 HCRTR1 (0.80) HCRTR1HCRTR2
SCHEMBL18589264 0.84 HCRTR1 (0.80) HCRTR1HCRTR2
SCHEMBL17017431 0.84 HCRTR1 (0.80) HCRTR1HCRTR2
SCHEMBL17017439 0.84 HCRTR1 (0.80) HCRTR1HCRTR2
SCHEMBL16666121 0.84 HCRTR1 (0.60) HCRTR1HCRTR2
SCHEMBL17017446 0.83 HCRTR1 (0.78) HCRTR1HCRTR2
SCHEMBL16655276 0.83 HCRTR1 (0.46) HCRTR1HCRTR2
Hydrochloric Acid SCHEMBL16655244 0.83 HCRTR1 (0.59) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057957-A1 CYCLOPENTYLBENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PSYCHOTIC AND COGNITIVE DISORDERS Takeda Pharmaceutical Company Limited (JP) 2016-08-24 EP disclosed
WO-2015055994-A1 CYCLOPENTYLBENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PSYCHOTIC AND COGNITIVE DISORDERS TAKEDA CAMBRIDGE LIMITED (GB) 2015-04-23 WO disclosed